Sysmex Advances ¥30 Billion Share Buyback, Repurchases 7.87 Million Shares

Sysmex ( (JP:6869) ) has shared an announcement.

Sysmex has disclosed the latest status of its ongoing share buyback program, reporting the acquisition of 6,177,600 shares of common stock for about ¥8.72 billion through market purchases on the Tokyo Stock Exchange between April 1 and April 30, 2026. This move forms part of a broader board-authorized plan allowing repurchases of up to 30 million shares, or 4.81% of outstanding stock, for a total of up to ¥30 billion through mid-September 2026.

Including the latest transactions, Sysmex has cumulatively repurchased 7,872,900 shares at a total cost of approximately ¥11.05 billion under the current authorization, signaling continued commitment to shareholder returns and capital efficiency. The scale and pace of the buyback underline management’s confidence in the company’s valuation and may support earnings per share and share price, affecting investors’ perception of Sysmex’s capital allocation priorities.

The most recent analyst rating on (JP:6869) stock is a Hold with a Yen1500.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.

More about Sysmex

Sysmex Corporation is a Japanese healthcare company specializing in diagnostic instruments, reagents, and related services for clinical laboratories and hospitals. The company focuses on in vitro diagnostics, particularly hematology and urinalysis systems, and is listed on the Tokyo Stock Exchange, where it actively manages its capital structure through share repurchase programs.

Average Trading Volume: 4,600,894

Technical Sentiment Signal: Sell

Current Market Cap: Yen830.3B

For detailed information about 6869 stock, go to TipRanks’ Stock Analysis page.